Avanos Medical (AVNS) Total Liabilities (2013 - 2026)

Avanos Medical has disclosed Total Liabilities across 14 years of filings, most recently posting $268.0 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $268.0 million, changed 0.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $268.0 million (changed 0.15% YoY), and the FY2025 annual result was $295.5 million, down 9.27% from the prior year.
• Total Liabilities came in at $268.0 million for Q1 2026 at Avanos Medical, down from $295.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $511.7 million in Q3 2022 to a low of $262.7 million in Q2 2025.
• The 5-year median for Total Liabilities is $433.4 million (2024), against an average of $403.0 million.
• Across the five-year window, Total Liabilities jumped 52.29% in 2022 and slumped 39.72% in 2025, its largest moves.
• Avanos Medical's Total Liabilities stood at $495.7 million in 2022, then dropped by 7.99% to $456.1 million in 2023, then fell by 28.59% to $325.7 million in 2024, then retreated by 9.27% to $295.5 million in 2025, then decreased by 9.31% to $268.0 million in 2026.
• The last three Total Liabilities figures came in at $268.0 million (Q1 2026), $295.5 million (Q4 2025), and $289.7 million (Q3 2025), per Business Quant data.